How Does NOBL Compare To Others In This Category; SDY, VIG And WDIV?

Matt Thalman - INO.com Contributor - ETFs


Today I would like to answer a question posed by you, a reader. A few weeks ago I mentioned one of my favorite ETF's the ProShares S&P 500 Dividend Aristocrats ETF (PACF:NOBL) and a reader named jab commented on the article and asked a question. Jab said,

"Thanks for the info on NOBL. Wasn't familiar with the term/category "dividend aristocrats." How does NOBL compare to others in this category like SDY, VIG, and WDIV?"

So, I would like to take some time and answer this question and give a little more detail on the different metrics I look for when trying to find the best ETF's to invest in when comparing similar category ETFs.

The four different ETF's we will be comparing today are the ProShares S&P 500 Dividend Aristocrats ETF, the SPDR S&P Dividend ETF (PACF:SDY), the Vanguard Dividend Appreciation Index Fund (PACF:VIG), and the SPDR S&P Global Dividend ETF (PACF:WDIV). So, let's get to it. Continue reading "How Does NOBL Compare To Others In This Category; SDY, VIG And WDIV?"

Biotech's Upward Trend - IBB Breaks $300

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction and Backdrop

As of recent, the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) has caught an upward trend and briefly crossed the $300 per share threshold for the first time over the past 9 months. The political backdrop has been very contentious and even more so after two of the three presidential debates have wrapped up. I’ve written several pieces evaluating the massive sell-offs in the biotech sector and how extraneous events such as oil, China, interest rates and to a large extent political threats are merely noise in the larger picture. These external events provide great buying opportunities in high-quality companies or the cohort itself as represented by the sector ETF, IBB as a proxy. There’s no doubt that there’s at least a loose correlation if not a direct correlation between opportunistic political posturing by political front-runners (i.e. Hilary Clinton and Bernie Sanders) and the chronic price suppression of IBB. Each time a tweet is pushed out to social media regarding drug pricing and/or specific attacks on pharmaceutical companies, the entire cohort takes a significant hit as reflected in the price action of IBB. I contend that political posturing played a major role in the sell-off of the healthcare cohort and more specifically biotech stocks. Drug pricing was used as a centerpiece and scapegoat for political gains. Continue reading "Biotech's Upward Trend - IBB Breaks $300"

Weekly Futures Recap With Mike Seery

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold futures in the December contract settled last Friday in New York at 1,255 an ounce while currently trading at 1,267 slightly higher for the trading week as gold remains relatively nonvolatile at the current time. Presently I am sitting on the sidelines as I’m not involved in any of the precious metals as prices are stuck in a 3 week sideways consolidation pattern. The U.S dollar is now hitting a 8 month high which is certainly not bullish the precious metals as it looks to me that the dollar will try to touch 100 in the coming weeks. I still believe that many of these markets will go sideways until the U.S election is finished which is still around 3 weeks away so be patient as there are still very few trends except in the grain market which is where my focus is at present. Rumors are circulating that the Federal Reserve might raise interest rates in the month of December and that is why the U.S dollar continues to move higher keeping a lid on many commodity prices here in the short-term. However, we have seen this story before.
TREND: LOWER
CHART STRUCTURE: EXCELLENT
Continue reading "Weekly Futures Recap With Mike Seery"

Is The Market Waiting Until Next Week To Make A Move?

Hello MarketClub members everywhere. Next week, Amazon.com (NASDAQ:AMZN), Apple Inc. (NASDAQ:AAPL) And Alphabet Inc. (NASDAQ:GOOG) all report earnings. This could be the catalyst to get the market out of the doldrums and the sideways pattern that I've been talking about for what seems like ever.

Yesterday Microsoft Corporation (NASDAQ:MSFT) announced its earnings a beat 76 cents vs. 68 estimates, that was enough to push the stock up above its 1999 highs of $59.97 in after-her-hour ours trading. It would appear that the turnaround efforts for Microsoft are on track under the guidance of Microsoft's CEO Satya Nadella.

The market has been remarkably quiet with most of the noise coming out of the presidential campaign this week.

Once again, MarketClub's Trade Triangles point the way to successful trading. If you are not tracking the Trade Triangles, you may decide to do so after looking at how they are positioned in many of the markets.

Looking at the major markets here are the minuscule changes so far this week (Thursday Closes). Continue reading "Is The Market Waiting Until Next Week To Make A Move?"

The Aftermath Of Brexit Has Created A Buying Opportunity

By: Joseph Hogue of Street Authority

Geopolitical issues have dominated the markets this year, and polls have been useless in lending any kind of certainty to asset prices.

OPEC has successfully managed expectations for a production freeze, even if an eventual deal is still unlikely, which has driven oil prices to nearly double since their February lows. Few would have predicted in January the momentum of the Trump campaign and the potential uncertainty on global trade.

As important as these events have been, however, 2016 will likely be remembered for one event in particular. Continue reading "The Aftermath Of Brexit Has Created A Buying Opportunity"